Lundbeck

Pharma

Axsome increases Auvelity's peak sales projection to $8B

A few days after gaining an FDA expansion for Auvelity to treat Alzheimer’s disease agitation, Axsome has projected its peak sales to reach $8 billion.

Kevin Dunleavy May 5, 2026 11:48am

Axsome's Auvelity wins FDA expansion for Alzheimer's agitation

May 1, 2026 11:42am

HHS headquarters as seen on April 02 2025

Trump admin rolls out 15 high-profile drugs for IRA price cuts

Jan 27, 2026 5:44pm

After Avadel setback, Lundbeck signals future M&A rigor

Jan 22, 2026 11:13am

Rising Stars in Pharma Marketing QA series header image

Rising Stars: Andrew Willett on bettering the world via comms

Dec 17, 2025 6:00am

tennis tennis ball tennis court ball in court ball in your court

With $2.37B offer, Alkermes sweetens deal to acquire Avadel

Nov 19, 2025 9:53am